File HF4577 ("Minnesota legalizes psilocybin therapy for patients") is before the Minnesota Legislature and has not been decided. Latest step (April 9, 2026): Motion to recall and re-refer, motion prevailed.
Minnesota file HF4577, before the Minnesota Legislature. Still to be decided as of 2026-04-09.
Eligible patients can access psilocybin in clinical settings Registered patients in Minnesota gain legal access to psilocybin-assisted therapy through licensed facilitators and health care practitioners operating under the program, subject to eligibility criteria and registration requirements established by the state.
Creates new clinical infrastructure and practitioner role The bill establishes a new class of "registered facilitators" and protections for suppliers and practitioners, potentially spurring workforce development, clinical training programs, and a regulated therapeutic market in Minnesota.
Access likely limited; program rules still being drafted The bill creates an advisory committee to establish eligibility criteria and operational rules, meaning eligible conditions, patient costs, geographic access, and final approval timelines remain undefined and could restrict availability when the program launches.
Psilocybin therapeutic use program established; protections for registered patients, registered suppliers, registered facilitators, and health care practitioners established; civil actions authorized; advisory committee established; and money appropriated.
Read the official record for HF4577
See everything up for a vote · This week in Minnesota · See what we have filed with the clerk